The results show that mutations in these two aldehyde dehydrogenase isoforms resulted in neurochemical evidence for ALDH inhibition and elevated striatal tissue DOPAL, followed by aging-related development of a PD-like phenotype. This evidence concerns the gene LDHA and Parkinson disease.